Abstract: Multi-morbidity and polypharmacy are common in older patients and increase their susceptibility to adverse drug events and hospitalizations. Rational drug prescription is critical; however, little is known about physicians' perspectives on how to prescribe drugs for older patients. The aim of this study was to explore physicians' approach to prescribe drugs to older patients, including identifying the drugs that physicians perceive to be risk drugs for older patients and comparing them with established lists of potentially inappropriate medications. Short semi-structured interviews were conducted with 50 medical specialists in 23 different specialities throughout Denmark who had contact with older patients. Content analysis was performed to identify the relevant themes. Regardless of their medical or surgical background and how often they prescribed drugs for older patients in daily work, all physicians expressed a cautious approach when prescribing risk drugs. Despite their shared caution, physicians had different strategies for prescribing drugs to older patients. The following strategies were identified: (1) 'Start low, go slow', (2) 'Trial and error', (3) 'Dose reduction', and (4) 'Never prescribe'. The most frequently mentioned risk drugs considered to cause hospitalization were vitamin K antagonists, opioids and diuretics; these drugs are relatively highly consistent with established lists of PIMs. Physicians were relatively knowledgeable about risk drugs. Although the physicians agreed that a cautious approach was needed when prescribing drugs for older people, there was no consensus about how to best accomplish this in practice.
Multi-morbidity and polypharmacy are common in older patients [1, 2] , and although these patients may benefit from pharmacotherapy, their risk of adverse drug events (ADEs) is high [3] . Up to 30% of hospital admissions in older patients are related to ADEs [4] [5] [6] . Furthermore, when preventive drug treatments are prescribed without considering patients' age, frailty, drug interactions or the expected time-to-benefit, patients' life expectancy may not be prolonged, and their quality of life may be compromised [7] .
The prescription of drugs to older people is thus a challenging issue, particularly considering the multi-morbidity and changes in pharmacodynamics and pharmacokinetics that occur in this population. Close attention needs to be paid to distinguish between ageing-related symptoms and drug-related side effects [8] . Although there are guidelines on which drugs to prescribe for certain diseases, as many older patients have multiple diseases, physicians may need to simultaneously prescribe additional drugs without guidelines that pertain to the specific situation [9] [10] [11] [12] .
Potentially inappropriate medications (PIMs) appear to be commonly used in older patients [13, 14] . PIMs are defined as drugs for which the risks of use outweigh the benefits [15] . The prevalence of PIMs in older patients ranges from 0 to 98% varying widely by setting, sample size and method of PIM measurement [13, 14, 16] . PIMs can potentially lead to ADEs, hospitalization and mortality [17] [18] [19] [20] [21] . The use of PIMs is also associated with low functional independence, low handgrip strength and reduced health-related quality of life [22] .
A cautious approach should be considered when prescribing drugs for older patients. Physicians can use an implicit or an explicit approach to drug prescription. Explicit approaches are drug-oriented or disease-oriented and can be applied with little or no clinical judgement. Implicit approaches are more patient-oriented and potentially the most sensitive [23] . To improve the practice of drug prescription for older patients, a better knowledge of physicians' approach to prescribing these drugs is needed. Therefore, the primary aim of this study was to investigate physicians' approach to prescribe drugs to older patients including identifying physicians' perceptions of drugs considered as risk drugs for older patients and comparing the reported risk drugs with previously established lists of PIMs.
Methods
Study design. The physicians' prescription practices are believed to be rooted in their professional experiences and opinions, and implicit judgements are continually used in clinical settings [24] . These factors can best be studied by applying qualitative methodologies, and therefore, we chose to use semi-structured face-to-face interviews to investigate the Danish physicians' approach to prescribing drugs to older patients. The interview guide consisted of questions on demographic characteristics (age, sex, place of work, medical speciality) and the physician's knowledge, attitude and practices regarding prescribing drugs for older patients. The current definition of PIMs is unclear, hence difficult to apply in daily clinical practice. We therefore applied this definition: drugs that may cause hospitalization or general practitioner (GP) consultation for older patients. The physicians could indicate either specific drugs or overall drug classes.
The interviews were also used to validate the PIMs for older patients included in a Danish list called the 'Red-Yellow-Green' list [22, 25] . This part of the interview was structured, and the results will be reported elsewhere.
Data collection.
A maximum variation sampling strategy was used [26] , selecting two physicians nationwide from every speciality that had contact with older patients. This design was chosen because it was suggested that physicians' approach to prescribe drugs for older patients could depend on their speciality. Physicians were randomly selected from a list obtained from the Danish Medical Association. This list contained contact information for 1310 medical specialists who had up to 5 years of experience as a medical specialist at the time of the interview. We then chose to include medical specialists with 0-5 years of experience. We assumed that younger medical specialists would have the most up-to-date knowledge of specific drugs in their speciality due to their recently completed education, thereby representing the best-case scenario. Four GPs were also selected, as general GPs manage over 80% of all prescribed drugs in Denmark [8] .
The selected physicians were initially contacted by letter or by email and were contacted again 2 weeks after the first contact by telephone or email if no response was obtained in the first place. If they did not want to participate or if they could not be reached, a new physician was randomly selected.
The selected physicians were initially contacted by letter, email or by telephone. If they did not want to participate or if they could not be reached, a new physician was randomly selected. If the physicians listed for a given speciality could not be reached, the snowball recruitment was used. Although we contacted colleagues and staff specialists who helped us contact possible physicians, we still could not find physicians with only 0-5 years of experience who wanted to participate; therefore, eight physicians with 8-15 years of experience were included.
The interviews were performed by the first author (LDC). All but three interviews were conducted at the physicians' workplace; the other three interviews were held at the physicians' private home. The physicians were not paid to participate and participated voluntarily.
Data analysis. The interviews were digitally recorded and transcribed verbatim by the first author and two research fellows. The first author read all the transcripts while listening to the interviews to ensure textual accuracy. The reported risk drugs were identified quantitatively, and these risk drugs and risk drug classes were categorized according to the Anatomical Therapeutic Chemical Classification System (ATC) [27] into overall drug groups. The number of times a specific risk drug or risk drug class was mentioned was registered. To assess whether the risk drugs reported by the participants were consistent with previously established lists of PIMs, that is to assess their level of knowledge, we compared mentioned drugs with the latest versions of the two most widely used lists of PIMs: the Beers criteria [28] and Screening Tool of Older People's Prescriptions (STOPP) list [29] , a new PIMs list from Europe: The EU(7)-PIM list [30] as well as with the Danish Red-YellowGreen list [25] . The STOPP list, in particular, has become a preferred tool to identify PIMs in many European countries [13] . The Red-Yellow-Green list is implemented in the primary sector of Denmark's health system [25] .
The interviews were analysed with regard to physicians' knowledge, attitude and practices towards prescribing drugs for older patients using qualitative content analysis, which consists of an iterative process [31] . Meaning units related to the prescription of drugs and risk drugs for older patients were extracted, condensed and coded. Patterns between the codes were identified first individually and then between participants to form themes. The first author (LDC) performed the coding and supervised by the last author (SK). Emerging themes were discussed with the other authors. The authors referred back to the transcripts to ensure that the analysis was based on the transcripts throughout the whole process [31] [32] [33] . Selected quotations that illustrated the identified themes required translation from Danish to English.
Ethics and consent statement. Approval from the Scientific Ethics Committee was not needed according to Danish law. Permission to manage personal data from the interviews was provided by the Danish Data Protection Agency on 1 February 2013 (j.no. 02087 HVH-201-005). Interviews were conducted nationwide to ensure confidentiality and anonymity, so the data provided could not be traced back to the individual respondent. Verbal informed consent was obtained from the physicians.
Results

Participant characteristics.
A random sample of 120 physicians were asked to participate in the interview. A total of 50 physicians within 23 different specialities participated in the study from June 2013 to November 2013 and from December 2014 to May 2015. The interviews lasted an average of 33 min. (ranging from 16 to 63 min.). The mean age of the participating physicians was 45.6 years, ranging from 36 to 65 years, and 50% (n = 25) were female. Almost half of the physicians (46%, n = 23) treated older patients more than five times a day, while only 6% (n = 3) treated older patients less than once a week (table 1) .
Expression of caution.
In general, the physicians were reluctant to specify what characterized a patient as old; they responded more to the Regardless of the physicians' medical or surgical background and how often they treated older patients, all of the physicians used a cautious approach when prescribing drugs for older patients. Common terms were as follows: 'cautious', 'risky', 'contemplate', 'consider', 'wary', 'observant', 'attentive', 'diligent', 'problematic' and 'reluctant'. The choice of term was not related to speciality, and some physicians used different words related to caution for the same drugs. Hence, many physicians highlighted that they were generally more careful when prescribing drugs for older patients, despite the fact that they did not want to define when a patient was considered old.
It is quite clear that if the patient is really old, you have to give caution to all types of medication that cause drowsiness, e.g., Morphine, Stesolid, and all those types of substances, because the patients often become confused after using them. (General surgeon) Prescription strategies. The physicians had different strategies for prescribing drugs to older patients. Four strategies were identified: (1) 'Start low, go slow', (2) 'Trial and error', (3) 'Dose reduction', and (4) 'Never prescribe'. The strategies 'Start low, go slow' and 'Trial and error' could be considered if the physicians were uncertain about prescribing drugs to older patients and acted according to this uncertainty. Hence, if the physicians were unsure of how to initiate medical treatment for the patient and how well old patients would tolerate medical treatment, they used 'Start low, go slow' or 'Trial and error'. Both strategies involved experimentation with a given treatment and cautious attempts to identify the best treatment plan. The two strategies differed in that the 'Start low, go slow' strategy started with as low a dose as possible and slowly and incrementally increased the dose if feasible. With this strategy, the physicians followed the patients' drug treatment closely and adjusted the dose as needed. The 'Trial and error' strategy provided a specific dosage and carefully monitored the results.
Nine physicians explained that they used the 'Start low, go slow' strategy for situations pertaining to the following drugs or drug classes: anti-Parkinson drugs, antihypertensive drugs, levodopa, and tramadol or no specific drugs.
There is a reason why the approach to treating older people is 'Start low, go slow'. That is the way it is. Medications are correlated to both kidney function and, to a lesser extent, to the less predictable liver function.
(Clinical pharmacologist)
Five medical physicians used the term 'With my back against the wall', which could be considered a component of the 'Trial and error' strategy. This term, 'With my back against the wall', was characterized by attempts to prescribe specific drugs that the patients needed for a particular disease. The physicians did not know how well the patient would tolerate the treatment, but it was provided nonetheless, despite the risk of ADEs. Only non-vitamin K anticoagulants were mentioned in the 'Trial and error' strategy.
I am working with a dreadful cocktail. . . with my back against the wall. There are no other options, because some patients have so many disorders that they have to have something for each one, if they are going to function in their own home. (Neurologist)
A surgeon also used the expression 'Fingers crossed' when prescribing non-vitamin K anticoagulants for older patients. This term is also part of the 'Trial and error' strategy and presented another way of expressing the physicians' uncertainty, as the physicians hoped that the patient would tolerate the treatment. In contrast, the 'Dose reduction' and 'Never prescribe' strategies could be perceived as options if the physicians were confident in how to prescribe drugs for older patients. The two strategies differed in that the physicians administered a specific drug in a reduced dose in the 'Dose reduction strategy', whereas they would not prescribe a specific drug in the 'Never prescribe' strategy. Seventeen physicians stated that they reduced the dose of specific drugs when prescribing them to older patients. Three physicians mentioned that they used specifically half of the drug dose when prescribing certain drugs to older patients. The 'Dose reduction' strategy was referred to with the following drugs or drug classes: antibiotics, anticoagulants, antihypertensives, anti-Parkinson drugs, beta-blocking agents, citalopram, dabigatran etexilate, digoxin, hypnotics, morphine, metformin, methotrexate, opioids, oxycodone, pethidine, prednisolone, quetiapine, rivaroxaban, sedatives, simvastatin and tramadol.
There is more attention to the fact that older patients only need half the dose of a given drug. (General medicine practitioner)
The last strategy was 'Never prescribe'. Twenty-five physicians explained that they would never prescribe certain drugs. Some used the alternative phrase, 'avoid specific drugs for older people'. The 'Never prescribe' strategy was referred to regarding the prescription of the following drugs or drug classes: alpha-blocking agents, antihypertensives, benzodiazepine, dabigatran etexilate, morphine, methotrexate, nitrofurantoin, non-steroidal anti-inflammatory drugs, pioglitazone, statins, tramadol and warfarin.
If you are 87 and you previously had a bleeding ulcer, then I would never dream of using a NSAID. (Infectious disease specialist)
The physicians did not appear to have a systematic prescription strategy for older patients, as some of the same drugs were mentioned under different strategies. For example, antihypertensives and tramadol were listed under (1) 'Start low, go slow', (2) 'Dose reduction', and (3) 'Never prescribe' and anti-Parkinson drugs were listed under (1) 'Start low, go slow', and (2) 'Dose reduction'. The drugs associated with the reported prescription strategies were all mentioned as risk drugs (table 2) .
Risk drugs.
Eighty-six specific risk drugs or risk drug classes were reported in the interviews; these drugs and drug classes were divided into 35 subclasses and subsequently into 13 overall drug groups (table 2). The overall groups of the reported drugs were as follows: antidiabetic, anti-Parkinson, antithrombotic, anti-infective, cardiovascular, central nervous system, corticosteroid, gastrointestinal, genitourinary, immunosuppressant, iron-chelating, muscular-skeletal system and obstructive airway disease agents. Of these, only six risk drugs or risk drug classes included in our list were not mentioned in the Red-Yellow-Green list, the Beers criteria, the EU(7)-PIM list or in the STOPP list (table 2 indicated by an asterisk*). When comparing the 35 subclasses of risk drugs or risk drug classes, 11 risk drugs or risk drug classes were found in the Red-Yellow-Green list, 18 in the Beers criteria, 16 in the EU (7)-PIM list and 26 in the STOPP list. Only nine risk drugs or risk drug classes were represented in all few lists/criteria. The risk drugs that were not listed in any of the three lists were as follows: (1) gentamicin, (2) fluconazole, (3) statins/simvastatin, (4) paracetamol, (5) magnesium hydroxide, (6) immunosuppressants/mycophenolic acid/sirolimus/calcineurin inhibitors/ciclosporin/tacrolimus/azathioprine/methotrexate, and (7) deferasirox.
Some of the drugs mentioned in the Beers criteria, the EU (7)-PIM list and STOPP list that were not described by the physicians were either not registered in Denmark or were used sparingly, for example ticlopidine or brompheniramine. Oestrogens appeared on the three lists, but they were not mentioned as risk drugs by the physicians. The drugs not mentioned by the physicians that were on the Red-Yellow-Green list were used very rarely or were over-the-counter drugs.
Discussion
The findings of this qualitative study showed that physicians expressed a cautious approach when prescribing drugs to older patients. The physicians in our study had different prescribing strategies, indicating a lack of consensus regarding how to manage risk drugs in older patients, despite the fact that they had a broad understanding of which drugs were risky for older patients.
Prescribing.
The physicians expressed caution when prescribing drugs for older patients, but they were reluctant to specify when a patient was characterized as old. A study by Cullinan et al. [34] similarly found that physicians felt a general sense of fear towards older patients because of their frailty and comorbidities. These results indicate that prescribing drugs to older patients was a complex issue for participating physicians.
This complexity was emphasized by the results showing a lack of a consistent use of specific strategies on how to prescribe drugs to older patients. Sinnott et al. [35] corroborated some of these results, finding that physicians used the phrase 'Best guesses' to describe their approach to prescribing drugs. Our results, however, point to more distinctions and nuances in the complexity of prescribing for older patients. Hence, some physicians used the 'Dose reduction' or 'Never prescribe' strategies, which were driven by certainty in how to prescribe drugs, whereas the 'Start low, go slow' and 'Trial and error' strategies were associated with uncertainty. One explanation why physicians in this study relied heavily on their individual judgement to determine which medications to prescribe and how, might be because there were no comprehensive guidelines available; the existing guidelines often did not reflect the medical complexity of older patients [36] . Further, existing guidelines, in general, provide guidance on prescribing rather than discontinuation of drugs which might be a relevant approach to the treatment of older patients; and many GPs are reluctant to discontinue medication [37] . Hence, the challenges of prescribing drugs for older complex medical patients should be seriously considered. The challenges may require a new paradigm for pharmacotherapeutics, including diagnostic skills, knowledge of risk drugs, and monitoring of symptoms, signs, and laboratory markers, recognition of risk and uncertainty, critical judgement and communication [38] [39] [40] . Such a paradigm could improve the level of evidence in the study of beneficial and adverse effects of drugs.
Risk drugs.
Drugs or drug classes that were classified as risk drugs by the physicians were correlated to a large overlap with the RedYellow-Green list, STOPP list, EU(7)-PIM list and Beers criteria [25, [28] [29] [30] . These results indicated that the physicians had a broad knowledge of drugs considered risky for older populations. The identification of risk drugs in our study was based on a method that differs from the methods used to create the Red-Yellow-Green list, Beers criteria, EU(7)-PIM list and STOPP list, which may explain the discrepancies between those lists and our findings. The existing lists were compiled to create a tool that would facilitate the identification of risky drugs in older patients. This study, however, indicated that the (continued) practice of prescribing drugs for older patients remained difficult, despite the availability of these lists and the agreement among all physicians to be cautious when prescribing drugs for older patients. This finding suggests a need for physicians to possess a wide range of skills when prescribing drugs to older patients [41, 42] . Cullinan et al. [42] found that physicians' working environments are often conducive to potentially inappropriate prescribing, given the workload, interruptions to writing prescriptions and lack of supportive IT systems. Prescriber education to prevent potentially inappropriate prescribing within specific drug classes has been shown to be effective, with physicians expressing interest in further geriatric-specific pharmacotherapy training [42, 43] . In Denmark, there is no recertification process for medical specialities as in the UK. Most physicians discuss challenging clinical cases with colleagues at multidisciplinary team meetings, but a recertification process is needed to maintain professional knowledge after the completion of specialist training [44] . Lubart and colleagues [45] found no improvement in the level of basic geriatric knowledge in community physicians from 1996 to 2006. This is a major concern and is reflected in the quality of care of older patients. This study indicates that specialist training must be organized and evidence-based. Our respondents were initially selected to obtain a maximum variation of younger Danish medical specialists. Almost all respondents were purposively yet randomly sampled throughout the nation to identify important approaches to prescribe drugs for older patients. We thereby covered a broad range of specialities at the cost of obtaining depth in prescribing culture within the different specialities. Individual face-toface interviews were considered an appropriate qualitative approach that could ensure high participation. Recall bias among physicians in correctly remembering how they prescribed drugs for older patients could be a limitation of the present study. As the study included mostly younger physicians, representing the best-case scenario as we assumed that younger medical specialists have the latest updated knowledge of specific drugs for their speciality, the actual knowledge of risk drugs could be lower than that measured in this study.
Furthermore, practices regarding drug prescription for older patients could differ even more according to differences in physicians' age and experience.
Conclusively, better education and a greater focus on prescribing drugs to older patients and managing their medical treatment with evidence-based practices are needed. Our findings suggest the need for increased knowledge of physicians about how to prescribe for older patients by introducing guidelines addressing these issues in clinical practice to increase high quality in clinical decision-making. More in-depth studies on the prescribing culture among specialists are necessary before a targeted training can be implemented. Additionally, more studies such as register studies are also needed to investigate exactly which drugs are potentially risky for older patients.
